Key facts
- This page summarizes David A. Ramsay's Form 4 filing for LA JOLLA PHARMACEUTICAL CO.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Nov 2021, 16:05.
David A. Ramsay - 17 Nov 2021 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 17 Nov 2021
- Net transaction value
- +$31,725
- SEC form
- 4
- Accepted by SEC
- 19 Nov 2021, 16:05:17 UTC
- Prior SEC filing
- 30 Sep 2021
- Next SEC filing
- 22 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Hearne, by power of attorney for David A. Ramsay
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
David A. Ramsay filed Form 4 for LA JOLLA PHARMACEUTICAL CO on 19 Nov 2021.
Change
- Previous filing in this sequence was filed on 30 Sep 2021.
- Current net transaction value: +$31,725.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LJPC
transaction
Common Stock
Purchase
- Transaction value
- $31,725
- Shares
- +7,500
- Change %
- +11%
- Price
- $4.23
- Shares after
- 75,500
- Date
- 17 Nov 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.